Theranos Investor Conference Presentation Deck

Sample Collection Device Design Challenges Hemolysis Clotting Altered cell morphology Theranos Design Considerations Capillary tubes Shape and diameter of capillary tubes and needles Anti-coagulant coating • Anti-coagulant concentration ● ● Rapid mixing of sample with anti-coagulant Fill volume indicators Optimized anti-coagulant concentration This technology has not been cleared or approved by the FDA and is not for sale in the United States. theranos 61

View entire presentation